Severe Hypoxia Defines Heterogeneity and Selects Highly Immature Progenitors Within Clonal Erythroleukemia Cells

We showed that resistance to severe hypoxia defines hierarchical levels within normal hematopoietic populations and that hypoxia modulates the balance between generation of progenitors and maintenance of hematopoietic stem cells (HSC) in favor of the latter. This study deals with the effects of hypoxia (0.1% oxygen) in vitro on Friend's murine erythroleukemia (MEL) cells, addressing the question of whether a clonal leukemia cell population comprise functionally different cell subsets characterized by different hypoxia resistance. To identify leukemia stem cells (LSC), we used the Culture Repopulating Ability (CRA) assay we developed to quantify in vitro stem cells capable of short‐term reconstitution (STR). Hypoxia strongly inhibited the overall growth of MEL cell population, which, despite its clonality, comprised progenitors characterized by markedly different hypoxia‐resistance. These included hypoxia‐sensitive colony‐forming cells and hypoxia‐resistant STR‐type LSC, capable of repopulating secondary liquid cultures of CRA assays, confirming what was previously shown for normal hematopoiesis. STR‐type LSC were found capable not only of surviving in hypoxia but also of being mostly in cycle, in contrast with the fact that almost all hypoxia‐surviving cells were growth‐arrested and with what we previously found for HSC. However, quiescent LSC were also detected, capable of delayed culture repopulation with the same efficiency as STR‐like LSC. The fact that even quiescent LSC, believed to sustain minimal residual disease in vivo, were found within the MEL cells indicates that all main components of leukemia cell populations may be present within clonal cell lines, which are therefore suitable to study the sensitivity of individual components to treatments.

[1]  M. Olivotto,et al.  Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations , 2006, Leukemia.

[2]  M. Blagosklonny Target for cancer therapy: proliferating cells or stem cells , 2006, Leukemia.

[3]  V. Praloran,et al.  Very Low O2 Concentration (0.1%) Favors G0 Return of Dividing CD34+ Cells , 2006, Stem cells.

[4]  C. Jordan,et al.  Mechanisms controlling pathogenesis and survival of leukemic stem cells , 2004, Oncogene.

[5]  M. Clarke,et al.  Self-renewal and solid tumor stem cells , 2004, Oncogene.

[6]  J. Dick,et al.  Concepts of human leukemic development , 2004, Oncogene.

[7]  F. Lacombe,et al.  Simultaneous Maintenance of Human Cord Blood SCID‐Repopulating Cells and Expansion of Committed Progenitors at Low O2 Concentration (3%) , 2004, Stem cells.

[8]  M. Simon,et al.  Expansion of human SCID-repopulating cells under hypoxic conditions. , 2003, The Journal of clinical investigation.

[9]  J. Lotem,et al.  Epigenetics wins over genetics: induction of differentiation in tumor cells. , 2002, Seminars in cancer biology.

[10]  V. Praloran,et al.  Hypoxia Modifies Proliferation and Differentiation of CD34+ CML Cells , 2002, Stem cells.

[11]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[12]  P. Iversen,et al.  Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats , 2000, Cell proliferation.

[13]  V. Praloran,et al.  Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent , 2000, Transfusion.

[14]  V. Praloran,et al.  The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability , 2000, Leukemia.

[15]  Bartolozzi,et al.  Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitors , 2000, British journal of haematology.

[16]  P. Glazer,et al.  Genetic instability induced by the tumor microenvironment. , 1996, Cancer research.

[17]  M. Olivotto,et al.  The role of hypoxia in the maintenance of hematopoietic stem cells. , 1993, Blood.

[18]  M. Blagosklonny,et al.  Antiangiogenic therapy and tumor progression. , 2004, Cancer cell.

[19]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[20]  V. Praloran,et al.  Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells. , 2002, Experimental hematology.